Herkes Claire 4

What Happened

• Claire Herkes, EVP Conferences at Gartner (IT), received two derivative awards reported on Feb 5, 2026: 2,303 performance-based restricted stock units (RSUs) and 14,022 stock appreciation rights (SARs). Both awards are reported at $0.00 acquisition price because they are equity compensation rather than open-market purchases.

Key Details

• Transaction date: 2026-02-05; Form filed: 2026-02-09 (appears timely—filed within the normal 2-business-day Form 4 window).
• Award details: 2,303 RSUs (performance-based) and 14,022 SARs (derivative).
• Price reported: $0.00 (standard for grants/awards; no immediate cash paid by the insider).
• Vesting/exercise terms:
  • RSUs: These are performance-based awards originally granted Feb 6, 2025; the number reported reflects certification of performance metrics. RSUs vest in four substantially equal annual installments beginning Feb 6, 2026. (Footnote F1)
  • SARs: Become exercisable in four substantially equal annual installments beginning Feb 5, 2027. (Footnote F2)
• Shares owned after the transaction: Not specified in the information provided.
• Transaction code: A = Award/Grant (derivative awards, not a purchase or sale).

Context

• These are compensation awards, not open-market purchases or sales. RSUs convert to shares when they vest; SARs provide value if the stock price rises above an exercise threshold when they become exercisable. Because the reported acquisition price is $0, there is no immediate cash exchange—real value depends on future vesting/exercise and Gartner’s stock price. As usual, awards reflect company compensation practices and should not be interpreted alone as a buy/sell signal.